Test Code LAB9772 UGT1A1-28 Genotyping for Irinotecan Toxicity
Methodology
Polymerase Chain Reaction (PCR) amplification of the promoter of UGT1A1 is performed with fluorescently-tagged analyte specific reagent primers as described (Shulman K, 2011). PCR Products are separated by capillary electrophoresis.
Performing Laboratory
Barnes-Jewish Hospital Laboratory
Specimen Requirements
Call Barnes-Jewish Hospital Molecular Diagnostics Laboratory at 314-454-8685 for collection instructions.
Form: Molecular Diagnostics Requisition
Specimen Type: Whole blood
Container/Tube: Lavender top (EDTA)
Specimen Volume: Full tube
Specimen Minimum Volume: 1-2 mL
Collection Instructions: Invert several times to mix blood. Clotted blood is not acceptable.
Specimen Transport Temperature
Ambient/Refrigerate/Frozen NO
Reference Values
An interpretive report will be provided.
Literature Reference:
Innocenti F, Undevia SD, Lyer L, et al. Genetic variants in the UDP-glucuronasyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 2004;22(8):1382-88.
Day(s) Test Set Up
Friday
Sample must be received in the laboratory by Thursday at 1600
Turnaround Time:
STAT: Director approval required
Routine: 2 to 7 business days
Test Classification and CPT Coding
81350
Additional Information
For BJH Laboratory Use Only
Analyte Stability:
Blood is stable 0 to 4 hours at ambient temperature, up to 168 hours refrigerated.
Laboratory Processing Instructions:
Test performed in BJH-Molecular Diagnostics.